A detailed history of Janus Henderson Group PLC transactions in Haemonetics Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 39,099 shares of HAE stock, worth $3.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,099
Previous 29,730 31.51%
Holding current value
$3.59 Million
Previous $2.54 Million 27.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $761,137 - $912,259
9,369 Added 31.51%
39,099 $3.23 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $447,885 - $536,595
6,287 Added 26.82%
29,730 $2.54 Million
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $55,445 - $63,715
688 Added 3.02%
23,443 $2 Million
Q3 2023

Nov 14, 2023

BUY
$82.56 - $93.49 $330 - $373
4 Added 0.02%
22,755 $2.04 Million
Q2 2023

Aug 14, 2023

SELL
$80.84 - $89.45 $2,344 - $2,594
-29 Reduced 0.13%
22,751 $1.94 Million
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $893,879 - $1.11 Million
12,287 Added 117.1%
22,780 $1.89 Million
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $774,908 - $903,867
10,493 New
10,493 $825,000
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $87,227 - $108,393
-1,378 Reduced 13.38%
8,924 $661,000
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $886 - $1,189
-18 Reduced 0.17%
10,302 $671,000
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $19 Million - $27.4 Million
-433,545 Reduced 97.67%
10,320 $652,000
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $37.7 Million - $56.7 Million
-760,819 Reduced 63.16%
443,865 $23.5 Million
Q3 2021

Nov 16, 2021

BUY
$57.6 - $70.59 $29.5 Million - $36.2 Million
512,612 Added 74.07%
1,204,684 $85 Million
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $35.9 Million - $82.1 Million
692,072 New
692,072 $46.1 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.71B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.